AEE788: a dual family epidermal growth factor receptor/ErbB2 and vascular endothelial growth factor receptor tyrosine kinase inhibitor with antitumor and antiangiogenic activity.
- Publication date
- 1 January 2004
- Publisher
- 'American Association for Cancer Research (AACR)'